checkAd

     189  0 Kommentare Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments - Seite 4

    CONTACT:  

    Monopar Therapeutics Inc.
    Investor Relations  
    Kim R. Tsuchimoto  
    Chief Financial Officer  
    kimtsu@monopartx.com  

    Follow Monopar on social media for updates: 

    Lesen Sie auch

    Twitter: @MonoparTx  LinkedIn: Monopar Therapeutics



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 4 von 4

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments - Seite 4 WILMETTE, Ill., March 28, 2024 (GLOBE NEWSWIRE) - Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced fourth quarter and full-year …